ArticleCurrent oncology (Toronto, Ont.)2023

Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre's Real-World Experience.

Yue Jennifer Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.